Substituted basic 2-aminotetralin in pharmaceuticals

Details Substituted basic 2-aminotetralin in pharmaceuticals Substituted basic 2-aminotetralin in pharmaceuticals

1991-04-09

1992-10-06

Raymond, Richard L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514319, 514305, 514255, 514431, 514432, 514447, 514430, 514450, 514459, 514471, 514603, 549346, 549424, 549449, 549514, 549 9, 549 13, 549 68, 564 92, 546206, 546133, 540484, 544395, 544398, 548542, 548557, 548950, A61K 3118, C07C31116

Patent

active

051532255

ABSTRACT:
For treatment of disorders of the central nervous system, the cardiovascular system or the intestinal tract, the new substituted basic 2-aminotetralins of the formula ##STR1## in which R.sup.1 represents hydrogen or alkyl,

REFERENCES:
patent: 4707497 (1987-11-01), Cecchi et al.
Chemical Abstracts, vol. 106, Feb. 2, 1987, No. 5, p. 94 106:28103s, Emerit et al, "Irreversible blockade of central 5-HT1A receptor . . . ".
Chistorn et al. CA 94: 36049t, CA 90: 87114t.
Ivanov et al. CA 88: 89624u.

Affiliated with

Also associated with

Rating

Substituted basic 2-aminotetralin in pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted basic 2-aminotetralin in pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted basic 2-aminotetralin in pharmaceuticals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1189569